Target intelligence / Profile preview

Voltage-gated tetrodotoxin-resistant sodium channel (TTX-R VGSC)

Target
TTX-R VGSC
Molecular classification
Ion channel, Voltage-gated sodium channel, Receptor
01

Overview

Voltage-gated tetrodotoxin-resistant (TTX-R) sodium channels are a specialized subset of the voltage-gated sodium channel family that remain functional in the presence of the potent neurotoxin tetrodotoxin. This group primarily includes the isoforms Nav1.5, Nav1.8, and Nav1.9, which are encoded by the genes SCN5A, SCN10A, and SCN11A, respectively (Catterall, 2000). While Nav1.5 is the principal sodium channel in the heart responsible for the rapid upstroke of the cardiac action potential, Nav1.8 and Nav1.9 are predominantly expressed in peripheral sensory neurons, particularly nociceptors (Bennett et al., 2019). These channels play a critical role in the initiation and propagation of pain signals, making them high-priority targets for the development of non-opioid analgesics (Eijkelkamp et al., 2012). Mutations in these channels are linked to various disorders, including cardiac arrhythmias (Nav1.5) and chronic pain syndromes like small fiber neuropathy or erythromelalgia (Nav1.8/1.9) (Dib-Hajj et al., 2013). Therapeutic strategies focus on developing selective inhibitors, such as Suzetrigine (VX-548), to block pain transmission without affecting cardiac function or central nervous system activity (Jones et al., 2023).

Other names
TTX-resistant sodium channelsTTX-insensitive sodium channelsNav1.5/Nav1.8/Nav1.9Tetrodotoxin-resistant voltage-gated sodium channels
02

Mechanism of action

Selective inhibition of the alpha-subunit pore to block sodium ion conductance or stabilization of the inactivated state to prevent repetitive firing.

03

Biological functions

Action potential generationNociceptionCardiac conductionSensory transductionSignal transduction
04

Disease associations

Neuropathic painInflammatory painCardiac arrhythmiaBrugada syndromeLong QT syndrome type 3ErythromelalgiaSmall fiber neuropathyVisceral pain
05

Safety considerations

Cardiotoxicity (due to off-target Nav1.5 inhibition)Arrhythmia riskParesthesiaDizzinessSelectivity challenges between TTX-resistant and TTX-sensitive isoforms
06

Interacting drugs

Suzetrigine (VX-548)

7 more in the full profile.

07

Biomarkers

Visual Analog Scale (VAS) for pain intensityNumeric Rating Scale (NRS) for pain intensityQuantitative Sensory Testing (QST)Electrocardiogram (ECG) intervals (e.g., PR and QRS duration for Nav1.5 safety)Intraepidermal nerve fiber density (IENFD)

Beyond the preview

Go deeper on Voltage-gated tetrodotoxin-resistant sodium channel (TTX-R VGSC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-gated tetrodotoxin-resistant sodium channel (TTX-R VGSC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call